Mechanism of dysregulated CXCR4 turnover in breast cancer cell invasion and its therapeutic implications.

Project: Research

Project Details

StatusFinished
Effective start/end date1/02/200631/07/2009

Funding

  • CRUK Cancer Research UK: £59,473.00
  • CRUK Cancer Research UK: £48,327.00
  • CRUK Cancer Research UK: £9,188.00
  • CRUK Cancer Research UK: £51,221.00